Literature DB >> 17086885

Liver resection for large-size hepatocellular carcinomas in 47 non-cirrhotic patients--no mortality and long-term survival.

L Capussotti1, A Muratore, M Amisano, P Massucco, R Polastri, H Bouzari.   

Abstract

BACKGROUND/AIMS: Few reports have analyzed short- and long-term outcomes in the subset of patients with hepatocellular carcinoma (HCC) on non-cirrhotic liver.
METHODOLOGY: From January 1985 to December 2002, 277 patients underwent liver resection for HCC; in only 47 the liver was normal or showed mild chronic hepatitis at histology.
RESULTS: A major hepatectomy (MHR) was accomplished in 37 cases (78.7%) including an extended hepatic resection in 18 (38.3%). In-hospital mortality was nil. The rate of complications was 40.4%. Overall and disease-free survival rates at 5 years were 30.9% and 33.9%. Fifteen patients are actually alive with a median survival of 33.3 months. By multivariate analysis, tumor size > 10cm and presence of satellite nodules were independent predictive factors of 5-year survival; median survival of thirteen patients with HCCs < or = 10cm and without daughter nodules was 60 months. Twenty-six patients had a margin less than 1cm and without cancer involvement; overall and recurrence-free survival rates were comparable to those of the patients with a > 1cm margin.
CONCLUSIONS: In the treatment of HCC without cirrhosis, major hepatic resections are often needed. Tumors less than 10cm in size and without satellite nodes are the best candidates for operation. The width of the resection margin is unimportant provided that there is no microscopic infiltration.

Entities:  

Mesh:

Year:  2006        PMID: 17086885

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  9 in total

1.  Proposal of new classification for postoperative patients with hepatocellular carcinoma based on tumor growth characteristics.

Authors:  Cui-Hong Zhu; Xiao-Hui Liu; Rui Cao; Xiong-Zhi Wu
Journal:  World J Gastroenterol       Date:  2013-09-07       Impact factor: 5.742

2.  Prognostic impact of underlying liver fibrosis and cirrhosis after curative resection of hepatocellular carcinoma.

Authors:  Peter Gassmann; Tilmann Spieker; Joerg Haier; Fabian Schmidt; Wolf Arif Mardin; Norbert Senninger
Journal:  World J Surg       Date:  2010-10       Impact factor: 3.352

3.  Resection of a giant hepatocellular carcinoma weighing over ten kilograms.

Authors:  Ming-Chen Ba; Shu-Zhong Cui; Sheng-Qu Lin; Yun-Qiang Tang; Yin-Bing Wu; Xiang-Liang Zhang
Journal:  World J Gastroenterol       Date:  2010-03-21       Impact factor: 5.742

4.  Adjuvant transarterial chemotherapy for margin-positive resection of hepatocellular carcinoma-a propensity score matched analysis.

Authors:  Alvina Jada Fok; Wong Hoi She; Ka Wing Ma; Simon H Y Tsang; Wing Chiu Dai; Albert C Y Chan; Chung Mau Lo; Tan To Cheung
Journal:  Langenbecks Arch Surg       Date:  2021-08-18       Impact factor: 2.895

5.  Long-term outcome of liver resection for hepatocellular carcinoma in noncirrhotic nonfibrotic liver with no viral hepatitis or alcohol abuse.

Authors:  Jean Lubrano; Emmanuel Huet; Basile Tsilividis; Arnaud François; Odile Goria; Ghassan Riachi; Michel Scotté
Journal:  World J Surg       Date:  2008-01       Impact factor: 3.352

6.  Assessment of hepatic functional reserve by cirrhosis grading and liver volume measurement using CT.

Authors:  Rong Tu; Li-Ping Xia; An-Le Yu; Ling Wu
Journal:  World J Gastroenterol       Date:  2007-08-07       Impact factor: 5.742

7.  Clinical characteristics and survival of European patients with resectable large hepatocellular carcinomas.

Authors:  Felice Giuliante; Agostino Maria De Rose; Vito Guerra; Francesco Ardito; Gennaro Nuzzo; Brian I Carr
Journal:  J Gastrointest Cancer       Date:  2013-09

8.  AROS Is a Significant Biomarker for Tumor Aggressiveness in Non-cirrhotic Hepatocellular Carcinoma.

Authors:  Jung-Hee Kwon; Keun Soo Ahn; Young Ho Moon; Jin Young Park; Hee Jung Wang; Kwan Yong Choi; Gundo Kim; Jae Won Joh; Kyeong Geun Lee; Koo Jeong Kang
Journal:  J Korean Med Sci       Date:  2015-08-13       Impact factor: 2.153

9.  Characterization and prognosis of patients with hepatocellular carcinoma (HCC) in the non-cirrhotic liver.

Authors:  Kerstin Schütte; Christian Schulz; Janine Poranzke; Kai Antweiler; Jan Bornschein; Tina Bretschneider; Jörg Arend; Jens Ricke; Peter Malfertheiner
Journal:  BMC Gastroenterol       Date:  2014-07-03       Impact factor: 3.067

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.